Value
6.8/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 9.5 |
| Fwd P/E | 2.2 |
| PEG | 10.0 |
| Analyst target | 3.0 |
- ▸Forward P/E: 52.6x
- ▸PEG: 0.29
CLOV · Why this verdict
Why Clover Health Investments (CLOV) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.9/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Overall business quality sits well below the 4.0 floor required for conviction, reflecting thin operating margins and no identifiable competitive moat — characteristics that make the growth story fragile if expansion slows even modestly. Quality | Quality improves above 4.0 as the business scales, driven by margin expansion becoming visible across at least two consecutive reporting periods. | →Stable |
| CounterEarly-stage growth in managed care is often accompanied by temporarily depressed margins; as the membership base scales, unit economics can improve substantially and quality metrics may follow with a lag. | ||
Revenue is expanding at 62% year-over-year, and the peer-rank analysis identifies this business as the top growth performer in its industry cohort — a pace of expansion that, if sustained, would substantially close the gap between current fundamentals and implied valuation. Growth | Revenue growth remains above 40% for the next two reported annual periods, and the business retains its industry growth-leader ranking. | →Stable |
| CounterGrowth in managed-care businesses can decelerate sharply as the membership base scales; the forward multiple of roughly 48 times earnings already prices in continued high growth, leaving no cushion if the rate normalizes. | ||
The stock currently trades at a level implying negative upside of roughly 27% to analyst consensus — meaning the market has priced in outcomes materially more optimistic than the median analyst view, creating asymmetric downside risk for new buyers. Bear case | For this concern to resolve, analyst targets would need to be revised above the current price of $4.81, or price would need to pull back to consensus levels. | →Stable |
| CounterAnalyst coverage is thin, dampening the statistical reliability of the consensus figure; rapid growth often causes targets to lag the stock, and if revenue momentum continues, widespread target upgrades may be forthcoming. | ||
The RSI has reached 70 — an overbought reading — while the put/call ratio stands at 2.47, indicating that options market participants are positioned for a near-term pullback at more than double the typical neutral rate. Risk | If the rally is sustainable, RSI should pull back to the 50–60 range within one to two months and the put/call ratio should normalize below 1.5. | →Stable |
| CounterAn overbought RSI in a strong uptrend can persist for weeks before resolving; heavy put positioning sometimes represents a contrarian bullish signal if the crowd's pessimism proves excessive. | ||
Overall business quality sits well below the 4.0 floor required for conviction, reflecting thin operating margins and no identifiable competitive moat — characteristics that make the growth story fragile if expansion slows even modestly.
→StableQuality
- Expectation
- Quality improves above 4.0 as the business scales, driven by margin expansion becoming visible across at least two consecutive reporting periods.
CounterEarly-stage growth in managed care is often accompanied by temporarily depressed margins; as the membership base scales, unit economics can improve substantially and quality metrics may follow with a lag.
Revenue is expanding at 62% year-over-year, and the peer-rank analysis identifies this business as the top growth performer in its industry cohort — a pace of expansion that, if sustained, would substantially close the gap between current fundamentals and implied valuation.
→StableGrowth
- Expectation
- Revenue growth remains above 40% for the next two reported annual periods, and the business retains its industry growth-leader ranking.
CounterGrowth in managed-care businesses can decelerate sharply as the membership base scales; the forward multiple of roughly 48 times earnings already prices in continued high growth, leaving no cushion if the rate normalizes.
The stock currently trades at a level implying negative upside of roughly 27% to analyst consensus — meaning the market has priced in outcomes materially more optimistic than the median analyst view, creating asymmetric downside risk for new buyers.
→StableBear case
- Expectation
- For this concern to resolve, analyst targets would need to be revised above the current price of $4.81, or price would need to pull back to consensus levels.
CounterAnalyst coverage is thin, dampening the statistical reliability of the consensus figure; rapid growth often causes targets to lag the stock, and if revenue momentum continues, widespread target upgrades may be forthcoming.
The RSI has reached 70 — an overbought reading — while the put/call ratio stands at 2.47, indicating that options market participants are positioned for a near-term pullback at more than double the typical neutral rate.
→StableRisk
- Expectation
- If the rally is sustainable, RSI should pull back to the 50–60 range within one to two months and the put/call ratio should normalize below 1.5.
CounterAn overbought RSI in a strong uptrend can persist for weeks before resolving; heavy put positioning sometimes represents a contrarian bullish signal if the crowd's pessimism proves excessive.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Revenue growing at 62% year-over-year places this among the fastest-growing businesses in its industry, but the stock already trades well above analyst consensus, quality remains below minimum investable thresholds, and overbought conditions combine with heavy protective options positioning to create a poor near-term entry.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
2.0/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 0.0 |
| Op margin | 1.5 |
| Net margin | 0.0 |
| Current ratio | 5.0 |
| Moat | 4.8 |
| Piotroski F | 4.4 |
- ▸No competitive moat
- ▸Quality concerns
Growth
10.0/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
| EPS growth | 10.0 |
- ▸Strong growth: 62% YoY
Momentum
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 3.6 |
| OBV | 1.0 |
| MA position | 9.0 |
| Volume | 0.9 |
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
4.1/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 2.2 |
| erm sentiment | 5.0 |
- ▸Below analyst target
Insider
3.9/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 4.5 |
| insider conviction | 2.0 |
| holder change | 5.1 |
- ▸Modest insider selling — $1,540,926 (0.056% of mkt cap)
Peer rank
4.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.9 |
| quality rank | 0.9 |
| growth rank | 9.1 |
- ▸Industry growth leader
Technical
4.5/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 3.0 |
| support resistance | 1.7 |
| 52w position | 8.8 |
Risk (lower is worse)
2.9/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 7.0 |
| days to cover | 8.2 |
| volatility | 0.0 |
| put call | 0.5 |
| implied vol | 0.1 |
| beta | 1.9 |
- ▸Elevated put/call: 1.92
- ▸High IV: 79%
Catalyst
3.3/10data confidence 75%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings timing | 5.0 |
| surprise avg | 0.0 |
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (6)
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:32d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:3.9<4.5
- ASYMMETRY:-2.2=NEGATIVE
Warning (0)
none
Reward-to-Risk
-2.20
Upside
-32.9%
Downside
15.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — Beta 2.42>1.3, MCap $2.8B<$5B
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Growth at 10.0 could not lift the engine output above the verdict floor. Failed gate signal: MOMENTUM:3.9<4.5.
The strongest dimensions are Growth at 10.0, Value at 6.8, and Technical at 4.5; the weakest are Quality at 2.0, Risk (lower is worse) at 2.9, and Catalyst at 3.3. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of -2.20 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Industry Leading Revenue Growth
Trip ifRevenue growth falls below 30% YoY for 2 consecutive reported periods.
- P2Stock Above Analyst Consensus
Trip ifAnalyst consensus price target is revised above $4.81 (the current stock price), restoring positive implied upside for new buyers.
- P3Overbought With Heavy Put Positioning
Trip ifRSI falls below 50 and put/call ratio drops below 1.5 for 4 consecutive weeks.
- P4Quality Below Minimum Threshold
Trip ifBusiness quality score rises above 4.0 on any subsequent assessment.